Антирак. Новый образ жизни - [117]
30. Ilnyckyj, A., J. Farber, M. Chang, et al., “A Randomized Controlled Trial of Psychotherapeutic Intervention in Cancer Patients,” Annals of the Royal College of Physicians and Surgeons of Canada 27 (1994): 93-96.
31. Cunningham, A. J., C. V. Edmonds, G. P. Jenkins, et al., “A Randomized Controlled Trial of the Effects of Group Psychological Therapy on Survival in Women with Metastatic Breast Cancer,” Psycho-Oncology 7, no. 6 (1998): 508-17.
32. Kissane, D. W., A. Love, A. Hatton, et al., “Effect of Cognitive-Existential Group Therapy on Survival in Early-Stage Breast Cancer,” Journal of Clinical Oncology 22, no. 21 (2004): 4255-60.
33. Spiegel, D., et al., “Effects of Supportive-Expressive Group Therapy on Survival of Patients with Metastatic Breast Cancer: A Randomized Prospective Trial,” Cancer 110, no. 5 (2007): 1130-38.
34. Everson, S. A., et al., “Hopelessness and Risk of Mortality and Incidence of Myocardial Infarction and Cancer,” Psychosomatic Medicine 58, no. 2 (1996): 113-121.
35. Chida, Y., et al., “Do Stress-Related Psychosocial Factors Contribute to Cancer Incidence and Survival?” Nature Clinical Practice Oncology 5, no. 8 (2008). Doi: 10.1038/ncponc1134.
36. Levy, S. M., R. B. Herberman, M. Lippman, et al., “Immunological and Psycho social Predictors of Disease Recurrence in Patients with Early-Stage Breast Cancer,” Behavioral Medicine 17, no. 2 (1991): 67-75.
37. Levy, S. M., R. B. Herberman, A. M. Maluish, et al., “Prognostic Risk Assessment in Primary Breast Cancer by Behavioral and Immunological Parameters,” Health Psychology 4, no. 2 (1985): 99-113.
38. Levy, S., R. Herberman, M. Lippman, et al., “Correlation of Stress Factors with Sustained Depression of Natural Killer Cell Activity and Predicted Prognosis in Patients with Breast Cancer,” Journal of Clinical Oncology 5, no. 3 (1987): 348-53.
39. Lutgendorf, S. K., A. K. Sood, B. Anderson, et al., “Social Support, Psychological Distress, and Natural Killer Cell Activity in Ovarian Cancer,” Journal of Clinical Oncology 23, no. 28 (2005): 7105-13.
40. Servan-Schreiber, D., Healing Without Freud or Prozac—Stress, Anxiety and Depression Without Drugs or Talk Therapy (London: Pan MacMillan, 2004).
41. Servan-Schreiber, D., The Instinct to Heal: Curing Depression, Anxiety and Stress Without Drugs and Without Talk Therapy (New York: Rodale, 2004).
42. Kabat-Zinn, J., Coming to Our Senses (New York: Hyperion, 2005).
43. Rinpoche, S., Le Livre Tibétain de la Vie et de la Mort (Paris: Livre de Poche, 2005).
44. Dekker, J., E. Schouten, P. Klootwijk, et al., “Heart Rate Variability from Short-Term Electrocardiographic Recordings Predicts Mortality from All Causes in Middle-Aged and Elderly Men: The Zutphen Study,” American Journal of Epidemiology 145, no. 10 (1997): 899-908.
45. Tsuji, H., F. Venditti, E. Manders, et al., “Reduced Heart Rate Variability and Mortality Risk in an Elderly Cohort: The Framingham Heart Study,” Circulation 90, no. 2 (1994): 878-83.
46. Bernardi, L., P. Sleight, G. Bandinelli, et al., “Effect of Rosary Prayer and Yoga Mantras on Autonomic Cardiovascular Rhythms: Comparative Study,” British Medical Journal 323 (2001): 1446-49.
47. Thayer, J. F., and E. Sternberg, “Beyond Heart Rate Variability: Vagal Regulation of Allostatic Systems,” Annals of the New York Academy of Sciences 1008 (2006): 361-72.
48. Umetani, K., D. Singer, R. McCraty, et al., “Twenty-four Hour Time Domain Heart Rate Variability and Heart Rate: Relations to Age and Gender over Nine Decades,” Journal of the American College of Cardiology 31, no. 3 (1999): 593-601.
49. Dekker, Schouten, Klootwijk, et al., “Heart Rate Variability from Short-Term Electrocardiographic Recordings . . .”
50. Bernardi, Sleight, Bandinelli, et al., “Effect of Rosary Prayer and Yoga Mantras on Autonomic Cardiovascular Rhythms.”
51. Lutz, A., L. Greischar, N. Rawlings, et al., “Long-term Meditators Self-Induce High-Amplitude Gamma Synchrony During Mental Practice,” Proceedings of the National Academy of Sciences USA 101 (2004): 16369-73.
52. Davidson, R. J., J. Kabat-Zinn, J. Schumacher, et al., “Alterations in Brain and Immune Function Produced by Mindfulness Meditation,” Psychosomatic Medicine 65, no. 4 (2003): 564-70.
53. Rosenkranz, M. A., D. C. Jackson, K. M. Dalton, et al., “Affective Style and in Vivo Immune Response: Neurobehavioral Mechanisms,” Proceedings of the National Academy of Sciences 100 (2003): 11148-52.
54. Gruzelier, J., A. Burgess, T. Baldewig, et al., “Prospective Associations Between Lateralized Brain Function and Immunte Status in HIV Infection: Analysis of EEG, Cognition and Mood over 30 Months,” International Journal of Psychophysiology 23 (1996): 215-24.
55. Kiecolt-Glaser, J. K., R. Glaser, D. Williger, et al., “Psychosocial Enhancement of Immunocompetence in a Geriatric Population,” Health Psychology 4, no. 1 (1985): 25-41.
56. Creswell, J. D., Myers, H. F., Cole, S. W., Irwin, M. R., “Mindfulness Meditation Training Effects on CD4+T Lymphocytes in HIV-1 Infected Adults: A Small Randomized Controlled Trial,”
